INSTITUTIONAL_OFFERING // SERIES_2026

Scale Your Impact

Apex BioGenix is architecting the future of biological infrastructure. We invite qualified partners to participate in the metabolic transformation of the North American industrial landscape.

Single Hub Allocation

Direct participation in the operational output of Hub 01. This path is designed for stakeholders seeking exposure to verified Gen-4 asset yields, biophysical transformation protocols, and established logistical revenue within the I-40/US-69 bisection.

Request Prospectus

Foundry Expansion

Capitalize the launch of a new Apex BioGenix node. We provide the biophysical stack, recursive yield intelligence, and site-selection data; you provide the infrastructure capital to establish a new regional bisection hub.

Discuss Expansion

REGULATORY DISCLOSURE: This communication does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any such offer or solicitation will be made only by means of a confidential Private Placement Memorandum (PPM) provided to accredited investors in accordance with applicable federal and state securities laws. Biological asset yields and sequestration metrics are based on internal foundry data and projections; actual results may vary based on deployment environment and climate indices. Apex BioGenix Inc. reserves the right to qualify all potential partners based on institutional criteria and operational alignment.